Trohman, Richard G.
Article History
Received: 26 March 2024
Accepted: 15 July 2024
First Online: 12 August 2024
Declarations
:
: Richard G. Trohman reported serving as an advisor to Boston Scientific/Guidant; receiving research grants from Boston Scientific/Guidant, Medtronic Inc, St Jude Medical (Abbott), Vitatron, and Wyeth- Ayerst/Wyeth Pharmaceuticals; serving as a consultant for Biosense Webster, Alta Thera Pharmaceuticals and Newron Pharmaceuticals P.s.A.; and receiving speakers fees or honoraria Boston Scientific/Guidant CRM, Medtronic Inc, Daiichi Sankyo, Alta Thera Pharmaceuticals and St Jude Medical (Abbott). Richard G. Trohman is an Editorial Board member of Cardiology and Therapy. Richard G. Trohman was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Richard G. Trohman attests that these potential conflicts of interest did not influence the contents of this manuscript.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.